Justify dose of Bilastine: CDSCO Panel tells Glenmark on FDC of Bilastine, Dextromethorphan ,Phenylephrine Syrup Dr. Divya Colin17 May 2022 7:10 PM ISTNew Delhi: Rejecting the pharmaceuticals major Glenmark proposal for bioequivalence (BE) study waiver of fixed dose combination drug Bilastine 3.3mg...
Fruit juices being labeled as ORS, ORSL Rehydrate: FSSAI initiates action Ruchika Sharma16 May 2022 5:10 PM ISTNew Delhi: In order to protect consumers' interests, the Food Safety and Standards Authority of India (FSSAI) has warned fruit-based beverages...
Include more sites from govt hospitals: CDSCO panel tells Intas on Tofacitinib Ointment 2% CT study Dr. Divya Colin15 May 2022 12:30 PM ISTNew Delhi: Directing the pharma major Intas Pharma to include more study sites from government hospitals geographically distributed in the country,...
Drug alert: CDSCO flags 27 medicine batches as not of standard quality Ruchika Sharma14 May 2022 2:48 PM ISTNew Delhi: In its latest drug safety alert, the Central Drugs Standard Control Organization (CDSCO) has flagged 27 medicine batches as not of Standard...
NPPA fixes price of 84 formulations, revises 1 Ruchika Sharma13 May 2022 3:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 84 formulations and has...
Government revokes anti-dumping duty imposed on Amoxicillin imports from China Ruchika Sharma12 May 2022 1:18 PM ISTNew Delhi: Through a recent gazette notification, the Central Government has revoked the anti-dumping duty imposed on 'Amoxycillin' also known as...
NPPA fixes retail prices of Linagliptin, Sitagliptin FDCs, Details Ruchika Sharma11 May 2022 6:00 PM ISTNew Delhi: Through a recent notice, National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the fixed dose combinations (FDCs)...
Glenmark gets CDSCO panel nod to manufacture and market COPD drug Dr. Divya Colin9 May 2022 6:52 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical major Glenmark pharmaceuticals, the Subject Expert Committee (SEC) of the Central...
CDSCO allows import of drugs with residual shelf life less than 60 percent till October 31, 2021 Susmita Roy8 May 2022 12:00 PM ISTNew Delhi: With an aim to ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard...
Paxlovid not be included in national treatment guidelines for COVID-19, says ICMR MD Bureau7 May 2022 1:01 PM ISTExperts from the Indian Council of Medical Research (ICMR) have not found a compelling reason to include the drug in the national treatment guidelines...
CDSCO panel directs GSK to generate safety, immunogenicity data on Indian population for INFANRIX-IPV Dr. Divya Colin6 May 2022 7:06 PM ISTNew Delhi: Rejecting pharmaceuticals major GSK's proposal to import INFANRIX-IPV in the country without conducting a local clinical trial, the Subject...
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine Susmita Roy5 May 2022 7:10 PM ISTNew Delhi: Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis...
